After Yield10 Bioscience (YTEN) announced that it has signed a Memorandum of Understanding, or MOU, with Mitsubishi to evaluate the establishment of a partnership to supply Camelina as a low-carbon feedstock oil for biofuels, Lake Street analyst Ben Klieve called this a "major step" towards a commercial partnership and "Yield10’s most material advancement to date as it moves from development to revenue generation." Klieve reiterates Buy rating and $12 price target on Yield10 shares.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on YTEN:
- Yield10 Surges after MOU with Mitsubishi
- Yield10 signs MOU with Mitsubishi to market Camelina as biofuel feedstock oil
- Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for Biofuel
- Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum
- Yield10 Bioscience reports Q3 EPS (71c), consensus (65c)
